Valuation: GuiZhou SanLi Pharmaceutical Co.,Ltd

Market Cap 4.38B 656M 589M 538M 491M 925M 61.71B 955M 6.49B 2.59B 32.93B 2.46B 2.41B 104B P/E 2024
19.4x
P/E 2025 106x
Enterprise Value 4.73B 709M 636M 581M 530M 999M 66.62B 1.03B 7B 2.79B 35.55B 2.66B 2.6B 112B EV / Sales 2024
2.48x
EV / Sales 2025 2.99x
Free-Float
40.59%
Yield 2024
2.62%
Yield 2025 0.51%
1 day+1.20%
1 week+3.39%
Current month+3.39%
1 month-13.28%
3 months-1.97%
6 months-1.61%
Current year-6.24%
1 week 10.59
Extreme 10.59
11.35
1 month 10.4
Extreme 10.4
12.48
Current year 9.51
Extreme 9.51
17.46
1 year 9.51
Extreme 9.51
17.46
3 years 9.51
Extreme 9.51
20.34
5 years 9.51
Extreme 9.51
21.28
10 years 8.82
Extreme 8.82
44.1
Manager TitleAgeSince
Chief Executive Officer 41 27/05/2024
Chief Executive Officer 41 01/09/2011
Director of Finance/CFO 39 01/11/2024
Director TitleAgeSince
Chairman 41 01/03/2018
Director/Board Member 41 01/03/2018
Director/Board Member 52 28/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
11/9/24 Sell

Chief Executive Officer

21,000,000 5.1428%
2/8/24 Buy

Director

13,000 0.0032%
5/8/23 Sell 25,000 0.0061%
Change 5-day change 1-year change 3-year change Capi.($)
+1.20%+3.39%-9.93%-43.92% 649M
+2.68%-1.23%+44.17%+135.67% 1,206B
+0.22%+2.60%+47.34%+88.31% 665B
-0.24%+0.81%+33.13%+110.93% 515B
+2.65%+0.60%+43.28%+67.83% 381B
+0.12%-0.84%+69.58%+43.69% 362B
+0.08%+1.34%+30.41%+58.10% 307B
+0.80%+1.23%+6.89%+34.44% 289B
-0.65%-1.39%+41.82%+73.82% 249B
+0.52%-1.31%+42.27%+124.19% 207B
Average +0.77%-1.25%+34.89%+69.31% 418.04B
Weighted average by Cap. +1.14%-1.96%+41.60%+93.99%

Financials

2024 2025
Net sales 2.14B 321M 288M 263M 240M 453M 30.18B 467M 3.17B 1.27B 16.11B 1.21B 1.18B 50.84B 1.7B 255M 229M 209M 191M 359M 23.97B 371M 2.52B 1B 12.79B 957M 937M 40.37B
Net income 274M 41.03M 36.8M 33.63M 30.7M 57.85M 3.86B 59.67M 405M 162M 2.06B 154M 151M 6.5B 46.25M 6.93M 6.21M 5.68M 5.18M 9.76M 651M 10.07M 68.43M 27.29M 347M 26M 25.44M 1.1B
Net Debt 108M 16.12M 14.46M 13.21M 12.06M 22.73M 1.52B 23.44M 159M 63.51M 809M 60.51M 59.22M 2.55B 349M 52.22M 46.83M 42.8M 39.07M 73.61M 4.91B 75.93M 516M 206M 2.62B 196M 192M 8.27B
Projected Income Statement - Annual - GuiZhou SanLi Pharmaceutical Co.,Ltd
Logo GuiZhou SanLi Pharmaceutical Co.,Ltd
Guizhou Sanli Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of pharmaceuticals. The products primarily include respiratory medications, tonics, gynecological medications, orthopedic medications, and cardiovascular medications. The specific pharmaceutical products include Kaihoujian Spray (children's version), Kaihoujian Spray, Qijiao Shengbai Capsules, Fuke Zaizao Pills, Zhike Huatan Pills, Huangqi Granules, and Qiangli Tianma Duzhong Capsules. The Company distributes its products within the domestic market.
Employees
1,887
Date Price Change Volume
09/11/26 CNY 10.97 +1.20% 9,743,323
06/11/26 CNY 10.84 -4.16% 10,412,200
05/11/26 CNY 11.31 +3.48% 11,517,300
04/11/26 CNY 10.93 +1.02% 10,419,400
03/11/26 CNY 10.82 -3.05% 10,035,500

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - GuiZhou SanLi Pharmaceutical Co.,Ltd
  1. Stock Market
  2. Stocks
  3. 603439 Stock